Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: Assessing patient interest, confidence, and physician prescribing practices
- PMID: 31647127
- PMCID: PMC6906990
- DOI: 10.1002/clc.23272
Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: Assessing patient interest, confidence, and physician prescribing practices
Abstract
Background: Prioritizing and managing multiple behavior changes following a cardiac hospitalization can be difficult, particularly among smokers who must also overcome a serious addiction.
Hypothesis: Hospitalized smokers will report a strong interest in smoking cessation (SC) but will receive little assistance from their physicians.
Methods: We asked current smokers hospitalized for an acute cardiac event to prioritize their health behavior priorities, and inquired about their attitude toward SC therapies. We also assessed SC cessation prescriptions provided by their physicians.
Results: Of the 105 patients approached, 81 (77%) completed the survey. Of these, 72.5% ranked SC as their greatest health change priority, surpassing all other behavior changes, including: taking medications, attending cardiac rehabilitation (CR), dieting, losing weight, and attending doctor appointments. Patients felt that SCM (44%), CR (41%), and starting exercise (35%) would increase their likelihood for SC. While most patients agreed that smoking was harmful, 16% strongly disagreed that smoking was related to their hospitalization. At discharge, medication was prescribed to ~32% of patients, with equal frequency among patients who reported interest and those who reported no interest in using medications.
Conclusion: The majority of hospitalized smokers with cardiac disease want to quit smoking, desire help in doing so, and overwhelmingly rate cessation as their highest health behavior priority, although some believe smoking is unrelated to their disease. The period following an acute cardiac event appears to be a time of great receptivity to SC interventions; however, rates of providing tailored, evidence-based interventions are disappointingly low.
© 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare no potential conflict of interests.
References
-
- Center for Disease Control and Prevention . Smoking and Tobacco Use; 2017. https://www.cdc.gov/tobacco/index.htm. Accessed Oct 12, 2019.
-
- Sochor O, Lennon RJ, Rodriguez‐Escudero JP, et al. Trends and predictors of smoking cessation after percutaneous coronary intervention (from Olmsted County, Minnesota, 1999 to 2010). Am J Cardiol. 2015;115(4):405‐410. - PubMed
-
- Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systemic review. JAMA. 2003;290:86‐97. - PubMed
MeSH terms
Grants and funding
- 1K24HL132008/National Heart, Lung and Blood Institute of the National Institutes of Health of Bethesda, MD
- K23 HL135440/HL/NHLBI NIH HHS/United States
- UL1 TR001064/TR/NCATS NIH HHS/United States
- UL1 RR025752/RR/NCRR NIH HHS/United States
- UL1RR025752/RR/NCRR NIH HHS/United States
- 1K23HL135440/National Heart, Lung and Blood Institute of the National Institutes of Health of Bethesda, MD
- UL1 TR000073/TR/NCATS NIH HHS/United States
- UL1TR001064/National Center for Advancing Translational Sciences, National Institutes of Health
- K24 HL132008/HL/NHLBI NIH HHS/United States
- HL11463104/National Heart, Lung and Blood Institute of the National Institutes of Health of Bethesda, MD
- UL1TR000073/National Center for Advancing Translational Sciences, National Institutes of Health
LinkOut - more resources
Full Text Sources
Medical